NCT07835542Not yet recruiting
Triton 1.5 Robotic System for Diagnostic Colonoscopy in the Middle East
Early Clinical Experience With the Triton 1.5 Robotic System for Diagnostic Colonoscopy in the Middle East
Source: ClinicalTrials.gov · Last updated 23 Sept 2026
Brief summary (registry, in English)
The purpose of this study is to gain early experience in the Triton 1.5 System in performing diagnostic, screening, surveillance, and basic therapeutic tasks (e.g., polypectomy for lesions ≤ 2 cm). This study will be the first clinical experience with Triton 1.5 in the Middle East, conducted at Cleveland Clinic Abu Dhabi.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 11 Sept 2026
- Start date
- 12 Oct 2026
- Primary completion date
- 30 Nov 2026
- Lead sponsor
- Neptune Medical
- Diseases
- Colorectal cancer
- NCT number
- NCT07835542
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 12 Oct 2026 to the primary completion date, 30 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous failed colonoscopy (except for inadequate bowel preparation)
- Lower gastrointestinal bleeding within 28 days prior to the colonoscopy day
- Subject receiving antiplatelet or anticoagulation therapy apart from low-dose aspirin
- Known coronary ischemia or cardiovascular stroke within 3 months prior to the colonoscopy procedure
- Received any investigational medicine or treatment within 28 days prior to the colonoscopy procedure
- Received or planning to receive any other endoscopic procedure within 4 weeks prior and 2 weeks after the colonoscopy procedure
- Participation in any concurrent clinical trial that may impact the results of this study
- Intra-Operative Criteria:
Other illness
- Any medical or physical condition/limitation that would contraindicate a conventional colonoscopy. This assessment will be made by the investigator.
- History of colorectal cancer, inflammatory bowel disease, polyposis syndrome, hereditary nonpolyposis colorectal cancer (Lynch) syndrome, sclerosing encapsulating peritonitis, active diverticulitis in last 6 months or toxic megacolon
- Known bleeding tendency such as hemophilia or coagulation factor deficiencies
- Known risk factors for abdominal adhesions such as history of complex abdominal or pelvis surgical procedures, based on investigator assessment
- History of radiotherapy to the abdomen or pelvis
- History of mesenteric ischemia
- Any intraoperative finding or condition that, in the Investigator's judgment, would make study participation unsafe or not in the subject's best interest (e.g., significant stricture, tight sigmoid colon precluding safe overtube passage).
Other
- Any active or magnetic implantable medical devices (e.g., pacemakers, defibrillators)
- BMI \> 45 kg/m2
- Pregnant participants
- Surgically altered colonic anatomy
- Known colonic stricture
- Known abdominal wall hernias
- Contraindication to the proposed sedation / anesthesia
- Inadequate bowel preparation, defined as a Boston Bowel Preparation Scale (BBPS) (Appendix A) score \< 2 in any segment.
Who the study is looking for
- Age ≥ 22 years
- Adults indicated for elective screening, surveillance or diagnostic colonoscopy
- Subject is willing and able to provide written informed consent prior to receiving any non-standard of care protocol specific procedures
- Subject is willing and able to comply with all protocol required preparation and follow- up visits
Age in the registry: 22 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cleveland Clinical Abu Dhabi Coordinator of this site? Confirm its status | Abu Dhabi | United Arab Emirates | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.